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Introduction
The magnitude of the problem of human immunodeficiency 
virus (HIV) infection in South Africa is illustrated in Fig. 1, 
which shows the rise of the HIV pandemic since 1990 and its 
stabilization after 2004. In 2010, 30.2% of all pregnant women 
who attended public sector health-care facilities were infected.1 
The prevalence of HIV infection among pregnant women is 
likely to remain high for at least the next two decades because 
the number of people receiving life-long antiretroviral therapy 
(ART) in South Africa is still increasing and is predicted to 
plateau at around 3 million in 2016.2
In 2011, an estimated 70.4% of maternal deaths in South 
Africa were associated with HIV infection,3 as were half of all 
deaths of children younger than 5 years.4 Consequently, the 
success of programmes for the prevention of mother-to-child 
transmission (PMTCT) of HIV is critical for reducing maternal 
and child mortality and morbidity.
Evolution of the PMTCT programme
Although the burden of HIV infection in South Africa had 
been large for many years, the country did not implement a 
PMTCT programme until 2002. The main steps in the evo-
lution of South Africa’s PMTCT policy are listed in Box 1.
In tandem with changes in policy, continuous efforts 
were also being made to improve the quality of the pro-
gramme using operational research. A review of the initial 
18 pilot sites for the PMTCT programme led to several 
recommendations for improving health-care systems, in-
cluding that the programme be scaled up to all facilities.5 It 
was also recommended that: training of front-line workers 
be improved; all health-care workers be given more support 
and supervision; managers’ commitment to the programme 
be increased; the PMTCT programme be integrated into 
existing primary health-care services, especially maternal 
services and services for women and children.
An evaluation of a quality improvement programme 
in one district in KwaZulu-Natal province showed that, al-
though HIV testing during pregnancy had become routine 
and universal, coverage was less extensive for other elements 
of the PMTCT cascade,6 such as ensuring that HIV-positive 
mothers are treated and continue on treatment; testing 
infants exposed to HIV; and identifying and treating HIV-
positive infants. It was recommended that these elements 
be given more attention and that programme data related to 
them be simplified and monitored regularly.7
Paying attention to data and indicators, such as the 
proportion of HIV-positive mothers receiving ART or pro-
phylaxis, is critical for improving the quality, coverage and 
impact of the PMTCT programme. This was demonstrated 
further in a study in 2008 in three districts in KwaZulu-
Natal where “a data quality improvement intervention that 
involved specific training for health-care workers on the 
importance of public health information, monthly data 
reviews and feedback, and regular data audits was effective 
in significantly increasing the completeness and accuracy of 
the data used to monitor PMTCT services in South Africa”.8 
Problem The World Health Organization has produced clear guidelines for the prevention of mother-to-child transmission (PMTCT) of the 
human immunodeficiency virus (HIV). However, ensuring that all PMTCT programme components are implemented to a high quality in 
all facilities presents challenges.
Approach Although South Africa initiated its PMTCT programme in 2002, later than most other countries, political support has increased 
since 2008. Operational research has received more attention and objective data have been used more effectively.
Local setting In 2010, around 30% of all pregnant women in South Africa were HIV-positive and half of all deaths in children younger than 
5 years were associated with the virus.
Relevant changes Between 2008 and 2011, the estimated proportion of HIV-exposed infants younger than 2 months who underwent 
routine polymerase chain reaction (PCR) tests to detect early HIV transmission increased from 36.6% to 70.4%. The estimated HIV transmission 
rate decreased from 9.6% to 2.8%. Population-based surveys in 2010 and 2011 reported transmission rates of 3.5% and 2.7%, respectively.
Lessons learnt Critical actions for improving programme outcomes included: ensuring rapid implementation of changes in PMTCT policy 
at the field level through training and guideline dissemination; ensuring good coordination with technical partners, such as international 
health agencies and international and local nongovernmental organizations; and making use of data and indicators on all aspects of the 
PMTCT programme. Enabling health-care staff at primary care facilities to initiate antiretroviral therapy and expanding laboratory services 
for measuring CD4+ T-cell counts and for PCR testing were also helpful.
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In addition, a 2008 initiative in which 
data were used to improve quality of 
care in the programme focused atten-
tion on the health districts with the 
worst performance and strengthened 
implementation of the PMTCT cascade 
by sharing good practices.9
Between 2008 and 2011, major 
changes in professional practice oc-
curred, including a shift towards 
nurses initiating and managing the 
use of ART. Nurses and midwives at 
primary care antenatal facilities were 
trained to provide ART for eligible 
pregnant women.
Results
In 2005, slightly fewer than 50% of all 
pregnant women were routinely tested 
for HIV infection. By 2009, testing 
was virtually universal. The maternal 
treatment regimen used for PMTCT 
has also changed over the past 10 years, 
from single-dose nevirapine to either 
dual therapy with nevirapine and 
azidothymidine from the 14th week 
of pregnancy onward or highly active 
antiretroviral therapy (HAART; Box 1) 
for women with a CD4+ T-cell count 
below 350 cells/mm3.
The testing of infants to identify 
HIV infection early has also increased. 
The results of routine tests in public 
health-care facilities are shown in 
Table 1. Between 2008 and 2011, the 
proportion of the estimated number of 
infants exposed to HIV who were tested 
before reaching the age of 2 months 
increased from 36.6% to 70.4%. Over 
the same period, the proportion of 
infants tested who were HIV-positive 
decreased from 9.6% to 2.8%.10
In 2010, the first national popula-
tion-based survey of the effect of the 
South African PMTCT programme on 
early HIV transmission from mother 
to child reported an overall transmis-
sion rate of 3.5%. When the survey was 
repeated in 2011, the transmission rate 
was found to be 2.7%.11,12
The main lessons learnt during im-
provement of the PMTCT programme 
were: changes in national PMTCT 
policy should be implemented rapidly 
at all facilities; the efforts of partner 
organizations should be coordinated 
with those of the formal health-care 
sector; and data and indicators should 
be used to provide motivation (Box 2).
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Box 1. Main steps in the evolution of South Africa’s policy on the prevention of mother-
to-child transmission of HIV, 1998–2011
•	 1998–1999: a PMTCT programme was started at two midwife obstetric units in Khayelitsha, Cape Town 
by the Western Cape Department of Health, despite the lack of a national policy.
•	 2000: thirteenth international HIV conference, Durban. Data presented indicated that antiretroviral drug 
regimens were effective in reducing mother-to-child transmission.
•	 2001: the South African Ministry of Health endorsed the establishment of two research sites in each of 
the nine provinces for a period of 2 years to understand better the operational challenges of introducing 
antiretrovirals during pregnancy to reduce mother-to-child transmission.15
•	 2001: this policy was challenged in the courts. In December 2001, the government was ordered by 
the court to develop a fully capable and effective national programme to reduce mother-to-child 
transmission by the following year.
•	 2002: the government challenged the court order, but was unsuccessful. The PMTCT programme 
commenced.
•	 2003: the government published a new operational plan for treating and caring for those infected with 
HIV. The plan included increased provision of nevirapine, the extension of treatment to all HIV-infected 
pregnant mothers and their children and the expansion of related health-care services, such as voluntary 
counselling and testing.
•	 2004: introduction of comprehensive care management and treatment of HIV-infected individuals. 
Pregnant women with a CD4+ T-cell count < 200 cells/mm3 became eligible for HAART.16
•	 2008: the Department of Health updated the PMTCT policy to include: (i) dual prophylaxis with 
azidothymidine and nevirapine from 28 weeks’ gestation; (ii) nevirapine treatment for pregnant women 
during labour and for their babies within 72 hours of delivery; and (iii) HAART for pregnant women with 
a CD4+ T-cell count < 200 cells/mm3.
•	 2008: the Minister of Health launched the national PMTCT accelerated plan (A-plan) which aimed to 
reduce mother-to-child transmission of HIV from 12% in 2008 to less than 5% by 2011, in accordance 
with the National Strategic Plan 2007–2011.
•	 2009: President Zuma’s speech on World AIDS Day outlined changes to be implemented in 2010. This 
gave a clear indication that the political leadership required to address the scale of the problem was 
available.
•	 2010: the Department of Health revised the PMTCT policy again to include lifelong HAART for HIV-
positive women with a CD4+ T-cell count ≤ 350 cells/mm3 and dual ART from 14 weeks onwards in 
the pregnancy for HIV-positive women with a CD4+ T-cell count > 350 cells/mm3, in line with option 
A of World Health Organization guidelines.17 Infant prophylaxis was daily nevirapine for 6 weeks for all 
infants. Daily nevirapine was continued for all breastfeeding infants whose mothers were not on HAART, 
to reduce postnatal transmission.18
•	 2011: following a national conference on breastfeeding, the Minister of Health endorsed a policy that 
breastfeeding should be exclusively used at public health facilities, with formula milk being reserved for 
when there are medical indications, and that the provision of free formula milk should be phased out.
•	 2011: in line with a call from global agencies, the Department of Health developed a national action 
framework for eliminating mother-to-child transmission of HIV.
ART, antiretroviral therapy; HAART, highly active antiretroviral therapy; HIV, human immunodeficiency 
virus; PMTCT, prevention of mother-to-child transmission.
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Challenges
Despite the remarkably successful 
implementation of the PMTCT pro-
gramme in South Africa, many challeng-
es remain. Some health districts have 
done better than others in ensuring that 
good quality data are collected routinely 
and that data are used by health workers 
and managers to continuously monitor 
and improve the programme. Moreover, 
there is also a need for mentoring and 
supportive supervisory systems that can 
help facilities use data effectively on a 
regular basis.7,13
In South Africa, pregnant women 
visit antenatal clinics at a relatively ad-
vanced stage of pregnancy; fewer than 
40% of them attend for the first time 
before 20 weeks’ gestation. Some preg-
nant women even go into labour without 
having attended an antenatal clinic once. 
The PMTCT policy introduced in 2010 
(Box 1) requires HIV-positive pregnant 
women to attend an antenatal clinic early, 
at 14 weeks’ gestation, so that interven-
tions can be started as soon as possible. 
Increasing early attendance will require 
interventions at both the individual 
and community levels to raise demand 
for services. In addition, changes in at-
titudes towards health-care services and 
in their organization will be needed to 
boost supply.
Ensuring that all infants undergo 
early HIV testing is another important 
challenge, as is making sure that all those 
who test positive are referred for treat-
ment. In addition, more attention should 
be given to testing infants exposed to 
HIV when they are older than 2 months, 
particularly since breast-feeding may 
result in on-going postnatal exposure 
to the virus.
Despite the substantial increase in 
the number of facilities that can admin-
ister ART, 15% of public health-care 
facilities in South Africa are still not 
able to initiate treatment (Department of 
Health, South Africa, unpublished data, 
2012). This inconveniences pregnant 
women, who may have to be referred to 
another facility for treatment initiation, 
and increases the possibility that they will 
be lost to follow-up.
South Africa is implementing a 
national action framework for PMTCT 
that covers the 5 years from 2012 to 
2016.14 The framework was tailored to 
individual districts and provinces and 
aims to provide a clear understanding 
of the operational issues that influence 
the continuous improvement of PMTCT 
programmes. In addition, there are 
on-going efforts to increase the ability 
of local health-care workers to collect 
high-quality data and use those data to 
improve the PMTCT programme.
If the national action framework 
for PMTCT is implemented in tandem 
with the envisaged strengthening of the 
health-care system, there is a high prob-
ability that, within the next 5 years, South 
Africa will be on the path to achieving 
the global goal of eliminating mother-
to-child HIV transmission by 2015. ■
Competing interests: None declared.
Table 1. Polymerase chain reaction testing for HIV in infants younger than 2 months 
born in public health-care facilities, South Africa, 2008–201110
Year No. of HIV- 
exposed infants 
No. (%) of HIV-exposed  
infants tested with PCR
No. (%) of infants with positive 
PCR results 
2008   240 739 88 006 (36.6)   8405 (9.6)
2009   232 227 120 354 (51.8)   7481 (6.2)
2010   241 645 144 501 (59.8)   6293 (4.4)
2011   241 645 170 030 (70.4)   4770 (2.8)
HIV, human immunodeficiency virus; PCR, polymerase chain reaction.
Box 2. Summary of the main lessons learnt
•	 Changes in PMTCT policy should be implemented rapidly at the field level: for example, 
changes in treatment regimes and in criteria for starting ART should be translated into 
action on the ground through training and guideline dissemination.
•	 There should be good coordination at the field level between the formal health-care sector 
and partner organizations, such as international health agencies and international and local 
nongovernmental organizations, to support PMTCT policies.
•	 Greater attention should be paid to data and indicators relating to all aspects of the PMTCT 
programme as this information can provide motivation.
ART, antiretroviral therapy; PMTCT, prevention of mother-to-child transmission.
صخلم
ايقيرفأ بونج في لفطلا لىإ ملأا نم يشربلا يعانلما زوعلا سويرف لاقتنا لىع ءاضقلا
 ةحضاو  ةيهيجوت  ئدابم  ةيلماعلا  ةحصلا  ةمظنم  تردصأ  ةلكشلما
 .لفطلا لىإ ملأا نم يشربلا يعانلما زوعلا سويرف لاقتنا نم ةياقولل
 نم لاقتنلاا  نم ةياقولا  جمانرب  تانوكم عيجم ذيفنت  نماض نأ لاإ
.تايدتح ضرفي قفارلما عيجم في ةيلاع ةدوجب لفطلا لىإ ملأا
 نم  ةياقولا  جمانرب  ايقيرفأ  بونج  ءدب  نم  مغرلا  لىع  بولسلأا
 نادلبلا  مظعم  دعب  ،2002  ماع  في  لفطلا  لىإ  ملأا  نم  لاقتنلاا
 تقلتو  .2008  ماع  ذنم  داز  سيايسلا  معدلا  نأ  لاإ  ،ىرخلأا
 تايطعلما  مادختسا  متو  مماتهلاا  نم  ًاديزم  ةيليغشتلا  ثوحبلا
.ةيلاعف رثكأ وحن لىع ةيعوضولما
 تاديسلا عيجم نم % 30 لياوح ناك ،2010 ماع في ةيلحلما عقاولما
 يشربلا يعانلما زوعلا سويرفل تايبايجإ ايقيرفأ بونج في لماولحا
 مهرماعأ لقت نيذلا لافطلأا ىدل ةافولا تلااح عيجم فصن ناكو
.سويرفلاب ًاطبترم تاونس 5 نع
 ةبسنلا تداز ،2011 لىإ 2008 نم ةترفلا في ةلصلا تاذ تا ّريرغتلا
 نيذلا  يشربلا  يعانلما  زوعلا  سويرفل  ينضرعلما  عضرلل  ةردقلما
 زايرميلوبلا لعافت تارابتخا مله يرجأو نيرهش نع مهرماعأ لقت
 يعانلما زوعلا سويرف لاقتنا نع ركبلما فشكلل ةينيتورلا لسلستلما
 سويرف لاقتنا لدعم ضفخناو .% 70.4 لىإ % 36.6 نم يشربلا
 تراشأو  .%  2.8  لىإ  %  9.6  نم  ردقلما  يشربلا  يعانلما  زوعلا
 تلادعم  لىإ  2011و  2010  في  تيرجأ  يتلا  ةيناكسلا  حوسلما
.لياوتلا لىع ،% 2.7و % 3.5 ةبسنب لاقتنا
 لئاصح  ينسحتل  ةمسالحا  تاءارجلإا  تلمش  ةدافتسلما  سوردلا
 ةياقولا ةسايس في تايرغتلل عيسرلا ذيفنتلا  نماض :ليي ام جمانبرلا
 للاخ  نم  نياديلما  ديعصلا  لىع  لفطلا  لىإ  ملأا  نم  لاقتنلاا  نم
 عم  ديلجا  قيسنتلا  نماضو  ؛ةيهيجوتلا  ئدابلما  شرنو  بيردتلا
 ةيلودلا تماظنلماو ةيلودلا ةيحصلا تلااكولا لثم ،ينينقتلا ءاكشرلا
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 في  تاشرؤلماو  تانايبلا  نم  ةدافتسلااو  ؛ةيموكلحا  يرغ  ةيلحلماو
 ناكو .لفطلا لىإ ملأا نم لاقتنلاا نم ةياقولا جمانرب بناوج عيجم
 ةياعرلا  قفارم  في  ةيحصلا  ةياعرلا  يفظوم  ينكتم  اًضيأ  ديفلما  نم
 عيسوتو  ةيرقهقلا  تاسويرفلا  تاداضمب  جلاعلا  ءدب  نم  ةيلولأا
 ةيئاتلا ايلالخا تاءاصحإ سايق لجأ نم ةيبرتخلما تامدلخا قاطن

























Élimination de la transmission du VIH de la mère à l’enfant en Afrique du Sud
Problème L’Organisation mondiale de la Santé a élaboré des lignes 
directrices claires pour la prévention de la transmission mère-enfant 
(PTME) du virus de l’immunodéficience humaine (VIH). S’assurer que tous 
les éléments du programme de PTME soient mis en œuvre de manière 
qualitative dans tous les établissements présente cependant des défis.
Approche Bien que l’Afrique du Sud ait lancé son programme de PTME 
en 2002, plus tard que la plupart des autres pays, le soutien politique a 
augmenté depuis 2008. La recherche opérationnelle a reçu davantage 
d’attention, et les données objectives ont été utilisées plus efficacement.
Environnement local En 2010, environ 30% de toutes les femmes 
enceintes en Afrique du Sud étaient séropositives, et la moitié de tous 
les décès d’enfants de moins de 5 ans étaient associée au virus.
Changements significatifs Entre 2008 et 2011, la proportion estimée 
de nourrissons de moins de 2 mois exposés au VIH, ayant subi une 
réaction en chaîne par polymérase (PCR) de routine visant à détecter 
la transmission précoce du VIH, est passée de 36,6% à 70,4%. Le taux 
estimé de transmission du VIH a diminué, passant de 9,6% à 2,8%. Les 
enquêtes basées sur la population en 2010 et 2011 ont signalé des taux 
de transmission de 3,5% et 2,7%, respectivement.
Leçons tirées Voici certaines actions essentielles pour améliorer 
les résultats du programme: assurer la mise en œuvre rapide des 
changements de politique de PTME sur le terrain, grâce à la formation et 
à la diffusion des lignes directrices; assurer une bonne coordination avec 
les partenaires techniques, comme les agences de santé internationales 
et locales et les organisations non gouvernementales; et utiliser les 
données et les indicateurs relatifs à tous les aspects du programme 
de PTME. Il est aussi utile de permettre au personnel soignant des 
établissements de soins de santé primaires d’initier un traitement 
antirétroviral et de développer les services de laboratoire pour les 
décomptes de cellules CD4 + T et les tests PCR.
Резюме 
Недопущение передачи ВИЧ от матери к ребенку в Южной Африке
Проблема Всемирная организация здравоохранения разработала 
четкие рекомендации по предотвращению передачи от матери 
ребенку (ПМР) вируса иммунодефицита человека (ВИЧ). Однако 
реализация всех компонентов программы ПМР с высоким 
качеством и во всех учреждениях оставляет желать лучшего.
Подход Хотя Южная Африка начала свою программу ПМР в 2002 
г., то есть, позже, чем большинство других стран, политическая 
поддержка программе возросла с 2008 г. Оперативным 
исследованиям стало уделяться больше внимания, а объективные 
данные стали использоваться более эффективно.
Местные условия В 2010 г. около 30% всех беременных женщин 
в Южной Африке показывали положительный анализ на ВИЧ, а 
половина всех случаев смерти среди детей до 5 лет была связана 
с данным вирусом.
Осуществленные перемены Между 2008 и 2011 гг., по оценкам 
ВОЗ, доля находящихся в группе риска заражения ВИЧ детей в 
возрасте до 2 месяцев, которым была проведена диагностика 
по методу полимеразной цепной реакции (ПЦР) для выявления 
ранней передачи ВИЧ-инфекции, увеличилась с 36,6% до 70,4%. 
Оцениваемый уровень передачи ВИЧ-инфекции снизился с 
9,6% до 2,8%. Опросы населения, проведенные в 2010 и 2011 гг., 
показали уровень передачи ВИЧ 3,5% и 2,7%, соответственно.
Выводы Следующие важные мероприятия позволили улучшить 
результаты программы: содействие быстрому применению 
изменений в области политики ПМР на местном уровне через 
обучение и распространение инструкций, обеспечение 
надлежащей координации с техническими партнерами, 
такими как международные учреждения здравоохранения, 
международные и местные неправительственные организации, 
а также практическое использование данных и показателей по 
всем аспектам программы ПМР. Также были полезны такие меры, 
как наделение медперсонала в учреждениях первичной медико-
санитарной помощи возможностью начинать антиретровирусную 
терапию и использование лабораторных служб для измерения 
числа Т-лимфоцитов CD4 + и диагностики по методу ПЦР. 
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Resumen
Cómo eliminar la transmisión del VIH de la madre al niño en Sudáfrica
Situación La Organización Mundial de la Salud ha presentado unas 
directrices claras para la prevención de la transmisión del virus de la 
inmunodeficiencia humana (VIH) de la madre al niño. No obstante, 
habrá que superar algunos desafíos para asegurar la puesta en marcha 
de todos los elementos del programa de prevención a fin de alcanzar 
un nivel de calidad elevado en todas las instalaciones.
Enfoque Aunque Sudáfrica inició su programa de prevención en el 
año 2002, más tarde que la mayoría de los países, el apoyo político 
ha aumentado desde 2008. Se ha prestado más atención a las 
investigaciones operativas y los datos objetivos se han utilizado con 
mayor eficacia.
Marco regional En 2010, alrededor del 30% de las mujeres embarazadas 
en Sudáfrica eran seropositivas, y la mitad de todas las muertes en niños 
menores de cinco años estuvieron asociadas al virus.
Cambios importantes Entre los años 2008 y 2011, la proporción 
estimada de niños menores de dos meses expuestos al VIH que se 
sometió a las pruebas rutinarias de reacción en cadena de la polimerasa 
aumentó del 36,6% al 70,4%, y la tasa estimada de transmisión del VIH 
se redujo del 9,6% al 2,8%. Las encuestas de población de los años 
2010 y 2011 reflejaron unas tasas de transmisión del 3,5% y el 2,7%, 
respectivamente
Lecciones aprendidas Las actividades fundamentales para mejorar los 
resultados del programa incluyeron: garantizar la implementación rápida 
de los cambios en la política de prevención de la transmisión a nivel 
de campo mediante cursos formativos y la difusión de las directrices; 
garantizar una coordinación adecuada entre los socios técnicos, 
tales como las agencias sanitarias internacionales y las ONG locales e 
internacionales; y utilizar los datos e indicadores acerca de todos los 
aspectos del programa de prevención de la transmisión del VIH de la 
madre al niño. También resultó muy útil permitir al personal sanitario de 
los centros de atención primaria iniciar terapias antirretrovirales y ampliar 
los servicios de laboratorio para realizar los recuentos de linfocitos T 
CD4+ y las pruebas de reacción en cadena de la polimerasa.
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